{{Rsnum
|rsid=11165354
|Gene=TGFBR3
|Chromosome=1
|position=91728765
|Orientation=plus
|GMAF=0.4766
|Gene_s=TGFBR3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 38.1 | 48.7 | 13.3
| HCB | 29.2 | 45.3 | 25.5
| JPT | 15.0 | 54.0 | 31.0
| YRI | 6.1 | 43.5 | 50.3
| ASW | 10.5 | 38.6 | 50.9
| CHB | 29.2 | 45.3 | 25.5
| CHD | 30.3 | 41.3 | 28.4
| GIH | 71.3 | 26.7 | 2.0
| LWK | 10.0 | 42.7 | 47.3
| MEX | 39.7 | 46.6 | 13.8
| MKK | 25.0 | 51.3 | 23.7
| TSI | 44.1 | 43.1 | 12.7
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23209189
  |Trait=Type 2 diabetes
  |Title=Genome-wide association study for type 2 diabetes in indians identifies a new susceptibility locus at 2q21.
  |RiskAllele=A
  |Pval=4E-6
  |OR=1.17
  |ORtxt=[1.10-1.25]
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}